Related Experiment Videos
Triplex-forming oligonucleotides as potential tools for modulation of gene expression
Faye A Rogers1, Janice A Lloyd, Peter M Glazer
1Department of Therapeutic Radiology and Genetics, Yale University School of Medicine, 15 York St., HRT 313, New Haven, CT 06520, USA.
Current Medicinal Chemistry. Anti-Cancer Agents
|August 17, 2005
Summary
Triplex-forming oligonucleotides (TFOs) offer precise genome editing by binding specific DNA sequences. These TFOs can permanently alter target genes or inhibit gene expression, showing promise for cancer therapy and genetic modification.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Triplex-forming oligonucleotides (TFOs) bind to specific DNA sequences in the major groove.
- Their sequence-specific binding enables targeted genomic interactions.
Purpose of the Study:
- To review the dual roles of TFOs in genome modification and gene expression inhibition.
- To explore factors influencing TFO efficacy in vitro and in vivo.
Main Methods:
- Review of existing literature on TFO applications.
- Analysis of studies demonstrating TFO-mediated DNA modification and gene silencing.
Main Results:
- TFOs can induce permanent DNA changes by activating cellular repair pathways.
- TFOs have shown potential in inhibiting gene expression for cancer therapy.
- Conflicting reports on TFO bioactivity highlight the need to understand influencing variables.
Conclusions:
- TFOs serve as versatile tools for targeted genome modification and gene expression modulation.
- Understanding variables affecting TFO efficacy is crucial for optimizing their therapeutic and research applications.